78 related articles for article (PubMed ID: 1131820)
1. Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.
Nimberg RB; Glasgow AH; Menzoian JO; Constantian MB; Cooperband SR; Mannick JA; Schmid K
Cancer Res; 1975 Jun; 35(6):1489-94. PubMed ID: 1131820
[TBL] [Abstract][Full Text] [Related]
2. Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.
Glasgow AH; Nimberg RB; Menzoian JO; Saporoschetz I; Cooperband SR; Schmid K; Mannick JA
N Engl J Med; 1974 Dec; 291(24):1263-7. PubMed ID: 4610386
[No Abstract] [Full Text] [Related]
3. Isolation of an immunosuppressive peptide fraction from human plasma.
Occhino JC; Glasgow AH; Cooperband SR; Mannick JA; Schmid K
J Immunol; 1973 Mar; 110(3):685-94. PubMed ID: 4569799
[No Abstract] [Full Text] [Related]
4. Isolation of a bone-resorptive factor from human cancer ascites fluid.
Nimberg RB; Humphries DE; Lloyd WS; Badger AM; Cooperband SR; Wells H; Schmid K
Cancer Res; 1978 Jul; 38(7):1983-9. PubMed ID: 657136
[TBL] [Abstract][Full Text] [Related]
5. Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea.
Ngai PH; Zhao Z; Ng TB
Peptides; 2005 Feb; 26(2):191-6. PubMed ID: 15629530
[TBL] [Abstract][Full Text] [Related]
6. Beta-endorphin-related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides, including the formerly unrecognized peptide beta-endorphin 1-18.
Vuolteenaho O
Acta Physiol Scand Suppl; 1984; 531():1-84. PubMed ID: 6091413
[TBL] [Abstract][Full Text] [Related]
7. Serum immunosuppression test as a new tool for immunodiagnosis of lung cancer.
Izumi T; Nagai S; Suginoshita T
Cancer Res; 1980 Feb; 40(2):444-7. PubMed ID: 6444275
[TBL] [Abstract][Full Text] [Related]
8. Improvement of phytohemagglutinin responsiveness of lymphocytes from cancer patients after washing in vitro.
Mannick JA; Constantian M; Pardrige D; Saporoschetz I; Badger A
Cancer Res; 1977 Sep; 37(9):3066-70. PubMed ID: 884664
[No Abstract] [Full Text] [Related]
9. Allogeneic suppression: inhibition of antibody plaque forming cells in vitro by non-sensitized lymphoid cells.
Friedman H
Transplant Proc; 1969 Mar; 1(1):574-6. PubMed ID: 4944273
[No Abstract] [Full Text] [Related]
10. [Effects of the spleen on immune state in patients with gastric cancer].
Qiu D
Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):334-7, 381. PubMed ID: 1332810
[TBL] [Abstract][Full Text] [Related]
11. Isolation of the homogeneous constituents from non-diffusible sugar-peptide (NSP) fraction originating from bovine plasma. III. The method of isolation and partial characterization of the four peptide constituents.
Klein A
Folia Histochem Cytochem (Krakow); 1983; 21(1):3-14. PubMed ID: 6873768
[TBL] [Abstract][Full Text] [Related]
12. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
Newberry WM; Sanford JP
J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
[TBL] [Abstract][Full Text] [Related]
13. Suppressor cell activity in tumor-bearing mice. III. Co-purification of a factor inhibiting cellular DNA synthesis and DNA polymerase activity.
Farrar WL; Elgert KD; Foo AS
J Immunol; 1981 Dec; 127(6):2339-44. PubMed ID: 6457873
[TBL] [Abstract][Full Text] [Related]
14. Prevention of graft-versus-host reaction in mice by picogram quantities of highly purified spleen-derived immunosuppressive peptide.
Millerioux-Di Giusto L; Kiger N; Duchange N; Lenfant M
Transplantation; 1981 Feb; 31(2):147-9. PubMed ID: 7020177
[No Abstract] [Full Text] [Related]
15. Immunological studies on Kawasaki disease: II. Isolation and characterization of an immunosuppressive factor in acute phase sera.
Hirao J; Yoshimura N; Homma N; Kano K
Clin Exp Immunol; 1987 Feb; 67(2):433-40. PubMed ID: 3111761
[TBL] [Abstract][Full Text] [Related]
16. An immunosuppressive peptide fraction in the serum of cancer patients.
Glasgow AH; Menzoian JO; Nimberg RB; Cooperband SR; Schmid K; Mannick JA
Surgery; 1974 Jul; 76(1):35-42. PubMed ID: 4135310
[No Abstract] [Full Text] [Related]
17. Characterization of colon-specific antigen-p and isolation of immunologically active tryptic peptides.
Shochat D; Archey RL; Pant KD; Dahlman HL; Gold DV; Goldenberg DM
J Immunol; 1981 Jun; 126(6):2284-9. PubMed ID: 6164726
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a sodium transport inhibitory factor, inhibitin, from cultured leukemic promyelocytes.
Morgan K; Mir MA
J Clin Invest; 1984 Oct; 74(4):1132-42. PubMed ID: 6090500
[TBL] [Abstract][Full Text] [Related]
19. Isolation of an inhibitor of type II interferon induction from tumor ascitic fluids.
Matsubara S; Suzuki M; Nakamura M; Edo K; Ishida N
Cancer Res; 1980 Jul; 40(7):2534-8. PubMed ID: 6248207
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative changes in serum oligopeptide components of patients with end stage malignant tumour disease.
Ribai Z; Vallent K; Gróf J; Menyhárt J; Idei M
Acta Physiol Acad Sci Hung; 1982; 60(3):129-34. PubMed ID: 7185253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
